Extracellular glycosaminoglycan changes in healthy and overgrown gingiva fibroblasts after cyclosporin A and cytokine treatments

Journal of Oral Pathology and Medicine

Volumn 33, Issue 6, 2004, Pages 346-353

  Stabellini, Giordano ^a,e   Calastrini, C ^b   Mariani, G ^b   Gioia, M ^a   Caramelli, E ^c   Gagliano, N ^a   Dellavia, C ^a   Moscheni, C ^a   Vizzotto, L ^a   Calvi, E M ^d  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d UNIVERSITY OF PERUGIA   (Italy)

^e Dipartimento di Anatomia Umana   (Italy)

Author keywords

Cyclosporin A; Gingival overgrowth; Glycosaminoglycans; Transforming growth factor ; Transforming growth factor 1

Indexed keywords

ACTIN; ALCIAN BLUE; ALPHA ACTININ; BETA TUBULIN; CHONDROITIN 4 SULFATE; CHONDROITIN 6 SULFATE; COLLAGEN; CONCANAVALIN A; CYCLOSPORIN A; CYTOKINE; DERMATAN SULFATE; GLYCOSAMINOGLYCAN; GLYCOSAMINOGLYCAN POLYSULFATE; HEPARAN SULFATE; HYALURONIC ACID; HYALURONIDASE; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 6; PROTEOGLYCAN; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA1; TUBULIN; VIMENTIN;

ADULT; ARTICLE; BIOACCUMULATION; BIOSYNTHESIS; CELL DAMAGE; CELL FUNCTION; CELL GROWTH; CELL HETEROGENEITY; CELL POPULATION; CELL STIMULATION; CELL SURFACE; CELL ULTRASTRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOSKELETON; DRUG CYTOTOXICITY; DRUG EFFECT; EXTRACELLULAR MATRIX; FEMALE; FIBROBLAST; FIBROBLAST CULTURE; GENETIC PREDISPOSITION; GINGIVA; GINGIVA HYPERPLASIA; GINGIVAL BIOPSY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; KAPOSI SARCOMA; LIVER TOXICITY; NEPHROTOXICITY; NEUROTOXICITY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SYNTHESIS; SULFATION; TRANSMISSION ELECTRON MICROSCOPY;

EID: 3142763800     PISSN: 09042512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2004.00217.x     Document Type: Article

References (48)

1. Thomson AW, Whiting PH, Simpson JG. Cyclosporin A on cell-mediated immunity. Clin Exp Immunol 1988; 71: 369-76.
2. Hamilton DV, Evans DB, Thiru S. Toxicity of cyclosporine-A in organ grafting. In: White D, ed. Cyclosporine-A. Amsterdam: Elsevier, 1982; 293.
3. Klintman GBG, Iwatsuki S, Starzl TE. Cyclosporin A hepatotoxicity in 66 renal allograft recipients. Transplantation 1981; 32: 488-9.
4. Beaman M, Parvin S, Veitch PS, Wallas J. Convulsions associated with cyclosporin A in renal transplant recipients. Br Med J 1985; 290: 139-40.
5. Bedani PL, Scirè Risichella I, Strumia R, et al. Kaposis's sarcoma in renal transplant recipients: pathogenetic relation between the reduced density of Langerhans cells and cyclosporin-A therapy. J Nephrol 1999; 12: 193-6.
6. Rostock MH, Fry HR, Turner JE. Severe gingival overgrowth associated with cyclosporine therapy. J Periodontol 1986; 57: 294-9.
7. Pernu HE, Knuttila ML. Macrophages and lymphocyte subpopulations in nefedipine- and cyclosporine A-associated human gingival overgrowth. J Periodontol 2001; 72: 160-6.
8. Kataoka M, Shimizu Y, Kunikiyo K, et al. Cyclosporin A decrease the degradation of type I collagen in rat gingival overgrowth. J Cell Physiol 2000; 182: 351-8.
9. Myrillas TT, Linden GJ, Marley JJ, Irwin CR. Cyclosporin A regulates interleukin-1beta and interleukin-6 expression in gingival: implications for gingival overgrowth. J Periodontol 1999; 70: 294-300.
10. Bolzani G, Della CR, Martelli JH, Graner E. Cyclosporin A inhibits production and activity of matrix metalloproteinases by gingival fibroblasts. J Periodontal Res 2000; 35: 51-8.
11. Little CB, Hughes CE, Curtis CL, Jones B, Caterson B, Flannery CR. Cyclosporin A inhibition of aggrecanase-mediated proteoglycan catabolism in articular cartilage. Arthritis Rheum 2002; 46: 124-9.
12. Linden GJ, Haworth SE, Haxwell AP, et al. The influence of transforming growth factor-beta 1 gene polymorphisms on the severity of gingival overgrowth associated with concomitant use of cyclosporine A and calcium channel blocker. J Periodontol 2001; 72: 808-14.
13. Bartold PM. Regulation of human gingival fibroblasts growth and synthetic activity by ciclosporine-A in vitro. J Periodontal Res 1989; 24: 314-21.
14. Barber MT, Savage NW, Seymour GJ. The effect of cyclosporin and lipopolysaccharide on fibroblasts: implications for cyclosporin-induced gingival overgrowth. J Periodontol 1992; 63: 397-404.
15. Mariani G, Calastrini C, Carinci F, Bergamini L, Calastrini F, Stabellini G. Ultrastructural and histochemical features of the ground substance in cyclosporin A-induced gingival overgrowth. J Periodontol 1996; 67: 21-7.
16. Stabellini G, Fiocchi O, Evangelisti R, et al. Effects of cyclosporin A on glycosaminoglycan synthesis and cytoskeletal organization in cultured human gingival fibroblasts. Med Sci Res 1990; 18: 895-6.
17. Ayanoglou CM, Lesty C. Cyclosporin A-induced gingival overgrowth in the rats: a histological, ultrastructural and histomorphometric evaluation. J Periodontal Res 1999; 34: 7-15.
18. Newell J, Irwin CR. Comparative effects of cyclosporin on glycosaminoglycan synthesis by gingival fibroblasts. J Periodontol 1997; 68: 443-7.
19. Fornoni A, Cornacchia F, Howard GA, Roos BA, Striker GE, Striker LJ. Cyclosporine A affects extracellular matrix synthesis and degradation by mouse MC3T3-E-1 osteoblasts in vitro. Nephrol Dial Transplant 2001; 16: 500-5.
20. 3H-glucosamine by fibroblast populations exposed to cyclosporine. J Periodontol 1994; 65: 565-7.
21. Stabellini G, carinci F, Bedani PL, et al. Cyclosporin A and transforming growth factor-β modify the pattern of extracellular glycosaminoglycans without causing cytoskeletal changes in human gingival fibroblasts. Transplantation 2002; 73: 1676-9.
22. Willershausen-Zonnchen B, Lemmen C, Zonnchen B, Hamm G, Schumacher U. Influence of nifedipine on the metabolism of gingival fibroblasts. Biol Chem Hoppe Seyler 1994; 375: 299-3.
23. Rocha LA, Martins RC, Werneck CC, Feres-Filho EJ, Silva LC. Human gingival glycosaminoglycans in cyclosporin-induced overgrowth. J Periodontal Res 2000; 35: 158-64.
24. Ankarcrona M, Zhivotovsky B, Holmstrom T, et al. Lamin and beta-tubulin fragmentation precede chromatin degradation in glutamate-induced neuronal apoptosis, Neuroreport 1996; 7: 2659-64.
25. Wolf G, Thaiss F, Stahl RA. Cyclosporine stimulates expression of transforming growth factor-beta in renal cells. Possible mechanism of cyclosporine antiproliferative effects. Transplantation 1995; 15: 227-41.
26. Mohamed MA, Robertson H, Booth TA, Balupuri S, Kirby JA, Talbot D. TGF-beta expression in renal transplant biopsies: a compared study between cyclosporin-A and tacrolimus. Transplantation 2000; 69: 1002-5.
27. James J, Irwin C, Linden G. Gingival fibroblast response to cyclosporin A and transforming growth factor B1. J Periodont Res 1998; 33: 40-8.
28. 1-hyaluronic acid interaction. Cell Tissue Res 1995; 281: 317-24.
29. Fukushma D, Bützow R, Hildebrand A, Ruoslathi E. Localization of transforming growth factor-β binding site in betaglycan. Comparison with small extracellular matrix proteoglycans. J Biol Chem 1993; 268: 22710-15.
30. Locci P, Lilli C, Marinucci L, Baroni T, Pezzetti F, Becchetti E. Embryonic skin fibroblasts release TGF alpha and TGF beta able to influence synthesis and secretion of GAG. Cell Mol Biol (Noisy-le-grand) 1993; 39: 415-26.
31. Pehlivan T, Mansour A, Spaczynski RZ, Duleba AJ. Effect of transforming growth factors-alpha and -beta on proliferation and apoptosis of rat theca-interstitial cells. J Endocrinol 2001; 170: 639-45.
32. Pagliarini A, Stabellini G, Calastrini C, Carinci P. Concanavalin A effect on glycosaminoglycans released by human embryonic and adult cultured fibroblasts. Med Sci Res 1988; 16: 871-3.
33. Di Persio CM, Jackson DA, Kenneth SZ. The extracellular matrix coordinately modulates liver transcription factors on hepatocyte morphology. Mol Cell Biol 1991; 11: 4405-14.
34. Dauca M, Bouziges F, Colin S, et al. Development of the vertebrate small intestine and mechanisms of cell differentiation. Int J Dev Biol 1990; 34: 205-18.
35. Scott JE, Dorling J. Differential staining of acid glycosaminoglycans (mucopolysaccharides) by Alcian blue in salt solutions. Histochimie 1965; 5: 221-33.
36. Carinci P, Pane GL, Simonelli I, Zaniboni G. Correlation between mesenchymal composition and epidermal differentiation in chick embryonic skin. Experientia 1975; 31: 586-7.
37. Patterson MK Jr. Measurement of growth and viability of cells in culture. In: Jacob WB, Pastan IH, eds. Methods in enzymology. New York: Academic press, 1979; 58: 141-293.
38. Conrad GW, Hamilton C, Haynes E. Differences in glycosaminoglycans synthesised by fibroblast-like cells from chicken cornea, heart, and skin. J Biol Chem 1977; 252: 6861-70.
39. Lowry OH, Rosebrough NJ, Farr AJ, Randall RJ. Protein measurement with Folin phenol reagent. J Biol Chem 1951; 193: 265-75.
40. Locci P, Baroni T, Lilli C, et al. TGFα and TGF-β antagonist effect in vitro on extracellular matrix accumulation by chick skin fibroblasts at two distinct embryonic stages. Int J Dev Biol 1999; 43: 157-65.
41. Worapamorn W, Li H, Haas HR, Pujic Z, Girjes AA, Bartold PM. Cell surface proteoglycan expression by human periodontal cells. Connect Tissue Res 2000; 41: 57-68.
42. Carinci P, Locci P, Evangelisti R, Marinucci L, Rossi L, Becchetti E. Relation between hyaluronan and sulphated glycosaminoglycan synthesis and degradation in cultured embryonic fibroblasts. Effect of concanavalin A and ammonium chloride administration. Cell Biochem Funct 1991; 9: 255-62.
43. Muraoka RS, Dumont N, Ritter CA, et al. Blockade of TGF-beta inhibits mammary tumor cell viability, migration, and metastases. J Clin Invest 2002; 109: 1551-9.
44. Hsu S, Boeke JL, Lewis JB, et al. Transforming growth factor beta 1 dysregulation in a human oral carcinoma tumor progression model. Cell Prolif 2002; 35: 183-92.
45. Hassell TM, Stanek EJ III. Evidence that healthy human gingiva contains functionally heterogeneous fibroblast subpopulations. Arch Oral Biol 1983; 28: 617-25.
46. Pagliarini A, Stabellini G, Carinci F, et al. Heterogeneity of fibroblasts derived from human free and attached gingiva. Glycosaminoglycan synthesis and effects of phenytoin (PHT) treatment. J Oral Pathol Med 1995; 24: 72-7.
47. Tipton DA, Stricklin GP, Dabbous MK. Fibroblast heterogeneity in collagenolytic response to cyclosporine. J Cell Biochem 1991; 46: 152-65.
48. Beck PL, Rosenberg IM, Xavier RJ, Kot T, Wong JF, Podolsky DK. Transforming growth factor-beta mediates intestinal healing and susceptibility to injury in vitro and in vivo through epithelial cells. Am J Pathol 2003; 162: 597-8.